• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用析因设计对微球-纳米颗粒复合口服给药系统进行制剂优化。

Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design.

作者信息

Bhavsar Mayank D, Tiwari Sandip B, Amiji Mansoor M

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, United States.

Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, United States.

出版信息

J Control Release. 2006 Jan 10;110(2):422-430. doi: 10.1016/j.jconrel.2005.11.001. Epub 2005 Dec 9.

DOI:10.1016/j.jconrel.2005.11.001
PMID:16338017
Abstract

The tremendous progress witnessed in the field of biotechnology with respect to discovery of therapeutic and antigenic proteins has propelled the need for development of suitable oral delivery devices for these and other macromolecules. In this study, we report the encapsulation of fluorescein isothiocyanate (FITC)-labeled gelatin nanoparticles into poly(epsilon-caprolactone) (PCL) microsphere (nanoparticle-in-microsphere oral delivery system, NiMOS) by double emulsion like technique and the influence of variables such as polymer concentration in organic phase, amount of nanoparticles added as internal phase, and the speed of homogenization on particle size of NiMOS using a 3(3) randomized full factorial design. A statistical model with interaction terms was derived to predict the particle size of the hybrid system. The results from multiple linear regression analysis and Student's t-test revealed that for obtaining large particles of NiMOS, a high polymer concentration and low speed of homogenization was necessary. In contrast, to obtain particles of smaller size, high speed of homogenization was found to be very important. The mathematical model obtained was validated for prediction of particle size. The encapsulation of gelatin nanoparticles in PCL microsphere was confirmed by fluorescent microscopy. Based on the statistical model we were also successful in producing NiMOS of less than 10 mum in size, which could be used as oral delivery system for therapeutic and antigenic macromolecules.

摘要

在生物技术领域,随着治疗性和抗原性蛋白质的发现取得了巨大进展,这推动了为这些及其他大分子开发合适口服给药装置的需求。在本研究中,我们报告了通过类似双乳液技术将异硫氰酸荧光素(FITC)标记的明胶纳米颗粒包封到聚(ε-己内酯)(PCL)微球中(纳米颗粒-微球口服给药系统,NiMOS),并使用3(3)随机全因子设计研究了诸如有机相中聚合物浓度、作为内相添加的纳米颗粒量以及匀化速度等变量对NiMOS粒径的影响。推导了一个包含交互项的统计模型来预测混合系统的粒径。多元线性回归分析和学生t检验的结果表明,为了获得较大粒径的NiMOS,需要高聚合物浓度和低匀化速度。相反,为了获得较小粒径的颗粒,发现高匀化速度非常重要。所获得的数学模型经验证可用于粒径预测。通过荧光显微镜确认了明胶纳米颗粒在PCL微球中的包封情况。基于统计模型,我们还成功制备了尺寸小于10μm的NiMOS,其可作为治疗性和抗原性大分子的口服给药系统。

相似文献

1
Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design.使用析因设计对微球-纳米颗粒复合口服给药系统进行制剂优化。
J Control Release. 2006 Jan 10;110(2):422-430. doi: 10.1016/j.jconrel.2005.11.001. Epub 2005 Dec 9.
2
Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).胃肠道分布及微球内纳米颗粒口服系统(NiMOS)的体内基因转染研究
J Control Release. 2007 Jun 22;119(3):339-48. doi: 10.1016/j.jconrel.2007.03.006. Epub 2007 Mar 15.
3
Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract.用于胃肠道局部质粒DNA递送的新型可生物降解聚合物纳米粒-微球制剂的研发。
AAPS PharmSciTech. 2008;9(1):288-94. doi: 10.1208/s12249-007-9021-9. Epub 2008 Jan 18.
4
Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.WOW工艺参数对负载FITC-葡聚糖的PLGA微球形态及突释的影响
Int J Pharm. 2007 Apr 4;334(1-2):137-48. doi: 10.1016/j.ijpharm.2006.10.036. Epub 2006 Oct 28.
5
The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.制剂变量对采用油中油单相溶剂蒸发法制备的载胰岛素聚(乳酸-乙醇酸共聚物)微球特性的影响。
Colloids Surf B Biointerfaces. 2009 Nov 1;74(1):340-9. doi: 10.1016/j.colsurfb.2009.08.003. Epub 2009 Aug 12.
6
On prilled Nanotubes-in-Microgel Oral Systems for protein delivery.用于蛋白质递送的微凝胶包封纳米管造粒口服系统
Eur J Pharm Biopharm. 2016 Apr;101:90-102. doi: 10.1016/j.ejpb.2016.01.014. Epub 2016 Feb 4.
7
Microsphere delivery of Risperidone as an alternative to combination therapy.利培酮微球给药作为联合治疗的替代方案。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):631-9. doi: 10.1016/j.ejpb.2013.07.012. Epub 2013 Jul 24.
8
Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease.基于微球制剂的口服白细胞介素-10基因递送用于炎症性肠病的局部转染和治疗效果
Gene Ther. 2008 Sep;15(17):1200-9. doi: 10.1038/gt.2008.67. Epub 2008 Apr 17.
9
Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism.单分散聚乳酸-乙醇酸共聚物微球的大分子释放:释放速率的控制及释放机制研究
J Pharm Sci. 2007 May;96(5):1176-91. doi: 10.1002/jps.20948.
10
Pharmacokinetics and Biodistribution Analysis of Small Interference RNA for Silencing Tissue Transglutaminase-2 in Celiac Disease After Oral Administration in Mice Using Gelatin-Based Multicompartmental Delivery Systems.使用基于明胶的多室递送系统经口给药后,用于沉默乳糜泻中组织转谷氨酰胺酶-2的小干扰RNA的药代动力学和生物分布分析。
Bioelectricity. 2020 Jun 1;2(2):167-174. doi: 10.1089/bioe.2020.0008. Epub 2020 Jun 17.

引用本文的文献

1
Oral delivery of stabilized lipid nanoparticles for nucleic acid therapeutics.用于核酸治疗的稳定脂质纳米颗粒的口服递送。
Drug Deliv Transl Res. 2025 May;15(5):1755-1769. doi: 10.1007/s13346-024-01709-4. Epub 2024 Sep 19.
2
Biocoating-A Critical Step Governing the Oral Delivery of Polymeric Nanoparticles.生物涂层——控制聚合物纳米粒子口服递送的关键步骤。
Small. 2022 Jul;18(26):e2107559. doi: 10.1002/smll.202107559. Epub 2022 May 23.
3
Microwave-assisted Preparation of Cross-linked Gelatin-Paracetamol Matrices: Optimization Using the D-optimal Design.
微波辅助制备交联明胶-扑热息痛基质:采用D-最优设计进行优化
Turk J Pharm Sci. 2021 Apr 20;18(2):167-175. doi: 10.4274/tjps.galenos.2020.48902.
4
Development, optimization and in vitro evaluation of oxaliplatin loaded nanoparticles in non-small cell lung cancer.载奥沙利铂纳米粒的制备、优化及其在非小细胞肺癌中的体外评价。
Daru. 2020 Dec;28(2):673-684. doi: 10.1007/s40199-020-00374-5. Epub 2020 Oct 22.
5
miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?胃肠道疾病中的 microRNAs:我们能否有效地经口服给予基于 RNA 的治疗药物?
Nanomedicine (Lond). 2019 Nov;14(21):2873-2889. doi: 10.2217/nnm-2019-0180. Epub 2019 Nov 18.
6
Site-specific intestinal DMT1 silencing to mitigate iron absorption using pH-sensitive multi-compartmental nanoparticulate oral delivery system.利用 pH 敏感多腔室纳米颗粒口服递药系统实现靶向肠道 DMT1 沉默以减轻铁吸收。
Nanomedicine. 2019 Nov;22:102091. doi: 10.1016/j.nano.2019.102091. Epub 2019 Oct 15.
7
Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases.载药纳米载体治疗自身免疫和慢性炎症性疾病。
Semin Immunol. 2017 Dec;34:61-67. doi: 10.1016/j.smim.2017.08.010. Epub 2017 Aug 30.
8
Oral nucleic acid therapy using multicompartmental delivery systems.口服核酸治疗的多腔室递药系统。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Mar;10(2). doi: 10.1002/wnan.1478. Epub 2017 May 24.
9
RNA interference-based nanosystems for inflammatory bowel disease therapy.基于 RNA 干扰的纳米系统治疗炎症性肠病。
Int J Nanomedicine. 2016 Oct 12;11:5287-5310. doi: 10.2147/IJN.S116902. eCollection 2016.
10
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease.口服细胞特异性纳米疗法治疗炎症性肠病的最新进展
World J Gastroenterol. 2016 Sep 14;22(34):7718-26. doi: 10.3748/wjg.v22.i34.7718.